Adjuvantation helps to optimise COVID-19 vaccine candidate

Lancet Infect Dis. 2021 Jul;21(7):891-893. doi: 10.1016/S1473-3099(21)00094-3. Epub 2021 Mar 8.

Authors

Jing-Xin Li¹, Feng-Cai Zhu²

Affiliations

¹ NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
² NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China. Electronic address: jszfc@vip.sina.com.

No abstract available

Publication types

Comment

MeSH terms

Adjuvants, Immunologic
COVID-19 Vaccines*
COVID-19*
Humans
SARS-CoV-2

Substances

Adjuvants, Immunologic
COVID-19 Vaccines